Doctor's Guide report on the approval of the "clot-buster" includes clinical trial results.

Prescribing information for the recombinant tissue plasminogen activator includes details on its indications, pharmacology, dosage, and adverse effects.

Maker of the clot-dissolving drug describes how the medicine works, what conditions it's used to treat, and what its side effects are.